The Miami longevity startup says it hopes to reach human trials during the nine-month program, after extensive preclinical development.
Link as first comment.
@longevitytech.bsky.social
@longevitytech.bsky.socialThe Miami longevity startup says it hopes to reach human trials during the nine-month program, after extensive preclinical development.
Link as first comment.
@eara.eu#Drug doubles life expectancy of pancreatic cancer patients 💊
The #FDA approved #daraxonrasib, from Revolution Medicines, after patients in a #Phase3 clinical trial lived twice as long as those on #chemotherapy. The drug was studied in #mice and #monkeys before #HumanTrials.
🔗 shorturl.at/BHYZd